Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2016

Nov 22, 2016

29828_dirs_2016-11-22_a4a8c2a6-b934-4342-8f9d-5688e19770b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-11-18

Reporting Person: MADIGAN JOHN W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-18 Common Stock M 105000 $20.705 Acquired 121761 Direct
2016-11-18 Common Stock S 105000 $74.8577 Disposed 16761 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-18 Non-qualified Stock Option (Right to Buy) $20.705 M 105000 Disposed 2017-05-09 Common Stock (105000) Direct

Footnotes

F1: Options vested in full on May 9, 2007, the date of grant.

F2: Sale prices reported for the transactions reported here range from $74.55 to $75.18. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.